Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federici

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Antioxidants (Basel, Switzerland)|November 11, 2022
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus InfectionÁngela Del Castillo-Izquierdo, José María Moreno-Navarrete, Jessica Latorre, et al.
Cell Reports. Medicine|December 20, 2023
Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesitySergio Quesada-Vázquez, Anna Castells-Nobau, Jèssica Latorre, et al.
Molecular Metabolism|February 12, 2022
ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acidsRossella Menghini, Lesley Hoyles, Marina Cardellini, et al.
Cardiovascular Diabetology|December 30, 2025
SCORE2-diabetes for predicting coronary artery disease: a cardiac CT study in a diabetic moderate-risk region populationRocco Mollace, Matteo Nardin, Matteo Arzenton, et al.
Atherosclerosis|October 31, 2012
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistanceSimonetta Bacci, Sabrina Prudente, Massimiliano Copetti, et al.
Diabetes|February 2, 2011
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patientsSimonetta Bacci, Stefano Rizza, Sabrina Prudente, et al.
Nature Medicine|June 27, 2018
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic healthLudivine Laurans, Nicolas Venteclef, Yacine Haddad, et al.
Microbiome|May 8, 2021
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiomeJordi Mayneris-Perxachs, Marina Cardellini, Lesley Hoyles, et al.
Gut|October 2, 2024
Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolismAnna Castells-Nobau, José Maria Moreno-Navarrete, Lisset de la Vega-Correa, et al.
Gut|January 7, 2026
Novel <i>myo</i>-inositol to butyrate fermentation pathway in the prevalent human gut species <i>Dysosmobacter welbionis,</i> a bacterium associated with improved metabolic and liver healthChi-Hsien Lee, Thi Phuong Nam Bui, Camille Petitfils, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Antioxidants (Basel, Switzerland)|November 11, 2022
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus InfectionÁngela Del Castillo-Izquierdo, José María Moreno-Navarrete, Jessica Latorre, et al.
Cell Reports. Medicine|December 20, 2023
Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesitySergio Quesada-Vázquez, Anna Castells-Nobau, Jèssica Latorre, et al.
Molecular Metabolism|February 12, 2022
ITCH E3 ubiquitin ligase downregulation compromises hepatic degradation of branched-chain amino acidsRossella Menghini, Lesley Hoyles, Marina Cardellini, et al.
Cardiovascular Diabetology|December 30, 2025
SCORE2-diabetes for predicting coronary artery disease: a cardiac CT study in a diabetic moderate-risk region populationRocco Mollace, Matteo Nardin, Matteo Arzenton, et al.
Atherosclerosis|October 31, 2012
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistanceSimonetta Bacci, Sabrina Prudente, Massimiliano Copetti, et al.
Diabetes|February 2, 2011
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patientsSimonetta Bacci, Stefano Rizza, Sabrina Prudente, et al.
Nature Medicine|June 27, 2018
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic healthLudivine Laurans, Nicolas Venteclef, Yacine Haddad, et al.
Microbiome|May 8, 2021
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiomeJordi Mayneris-Perxachs, Marina Cardellini, Lesley Hoyles, et al.
Gut|October 2, 2024
Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolismAnna Castells-Nobau, José Maria Moreno-Navarrete, Lisset de la Vega-Correa, et al.
Gut|January 7, 2026
Novel <i>myo</i>-inositol to butyrate fermentation pathway in the prevalent human gut species <i>Dysosmobacter welbionis,</i> a bacterium associated with improved metabolic and liver healthChi-Hsien Lee, Thi Phuong Nam Bui, Camille Petitfils, et al.
Pageof 22